Log In
Print
BCIQ
Print
Print this Print this
 

Recentin, cediranib (AZD2171)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionTyrosine kinase inhibitor of vascular endothelial growth factor (VEGF) receptors 1, 2 and 3
Molecular Target Vascular endothelial growth factor (VEGF) receptor 1 (FLT1) (VEGFR-1) ; Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2)
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today